Play all audios:
US agencies propose expanded reporting of drug-test data. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS
OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on
SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about
institutional subscriptions * Read our FAQs * Contact customer support Authors * Sara Reardon View author publications You can also search for this author inPubMed Google Scholar RELATED
LINKS RELATED LINKS RELATED LINKS IN NATURE RESEARCH Tamiflu report comes under fire 2014-Apr-22 Half of US clinical trials go unpublished 2013-Dec-03 Drug-company data vaults to be opened
2013-Mar-27 RELATED EXTERNAL LINKS The Interactive Pharma Scandal Story Clinical Trials website RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reardon,
S. Clinical-trial rules to improve access to results. _Nature_ 515, 477 (2014). https://doi.org/10.1038/515477a Download citation * Published: 25 November 2014 * Issue Date: 27 November 2014
* DOI: https://doi.org/10.1038/515477a SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative